コンテンツへスキップ
Merck
  • Longitudinal changes in leukocyte telomere length and mortality in elderly Swedish men.

Longitudinal changes in leukocyte telomere length and mortality in elderly Swedish men.

Aging (2018-10-31)
Xiaotian Yuan, Magnus Kronström, Mai-Lis Hellenius, Tommy Cederholm, Dawei Xu, Per Sjögren
要旨

Telomere length (TL) is considered an indicator of aging and age-related diseases, but longitudinal studies on TL changes and mortality are few. We therefore analyzed TL and longitudinal changes in TL in relation to all-cause, cardiovascular, and cancer mortality in 247 elderly Swedish men. TL was determined by the qPCR method at ages 71 and 81 and subsequent mortality cases were identified from the Swedish cause-of-death registry. Cox proportional hazard ratios were calculated during a mean follow-up of 7.4 years, during which 178 deaths occurred. Short telomeres at baseline was strongly associated with mortality risks, with a 40 to 70% increased risk of all-cause mortality, and a 2-fold increased risk of cancer mortality. Longitudinal changes in TL revealed shortening in 83% of individuals, whilst 10% extended their telomeres. TL attrition did not predict all-cause or cancer mortality, but we found a 60% decreased risk for cardiovascular mortality in those who shortened their telomeres. Our data show an increased risk of mortality in individuals with short baseline telomeres, but no relations to all-cause, and cancer mortality for changes in TL. Intriguingly, our data indicate lower risk of cardiovascular mortality with shortening of telomeres. The latter should be interpreted cautiously.

材料
製品番号
ブランド
製品内容

Roche
TeloTAGGGテロメア長アッセイ, sufficient for ≤50 reactions, kit of 1 (15 components), suitable for cell culture